Table of Contents
Volume 4 | Issue 2
Publication Date: September 2005- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Meeting Highlights | ||
73-78 |
Highlights from: the 5th Annual International Congress on Monoclonal Antibodies in Cancer; Quebec City, Canada; August 2005; the 5th International Prostate Cancer Congress; Rio Grande, Puerto Rico; July 2005; the 41st Annual Meeting of the American Society of Clinical Oncology; Orlando, Florida; May 2005 G. Kesava Reddy, Preeta Tyagi, Eric Nadler, Vinay K. Jain |
|
Researches in Brief | ||
80-82 |
Potential Role of Inhibiting the Vascular Endothelial Growth Factor Pathway in Advanced Prostate Cancer Preeta Tyagi, Eric Nadler, Arif Hussain |
|
83-85 |
Early Clinical Data and Potential Clinical Utility of Novel Histone Deacetylase Inhibitors in Prostate Cancer G. Kesava Reddy, Eric Nadler, Arif Hussain |
|
Original Contributions | ||
86-90 |
Second-Line Chemotherapy for Prostate Cancer: Patient Characteristics and Survival Kathleen W. Beekman, Mark T. Fleming, Howard I. Scher, Susan F. Slovin, Nicole M. Ishill, Glenn Heller, W. Kevin Kelly |
|
91-99 |
Safety and Tolerability of PCK3145, a Synthetic Peptide Derived from Prostate Secretory Protein 94 (PSP94) in Metastatic Hormone-Refractory Prostate Cancer Robert E. Hawkins, Luc Daigneault, Richard Cowan, Richard Griffiths, Chandra Panchal, Anne Armstrong, Jackie Fenemore, Alan Irvine, Kasia Sereda, Hélène Dulude |
|
100-108 |
A Measure of Health-Related Quality of Life Among Patients with Localized Prostate Cancer: Results from Ongoing Scale Development Christie A. Befort, Michael J. Zelefsky, Peter T. Scardino, Evelinn Borrayo, R. Brian Giesler, Michael W. Kattan |
|
109-112 |
Quantitative Computed Tomography Perfusion of Prostate Cancer: Correlation with Whole-Mount Pathology Elizabeth P. Ives, Melissa A. Burke, Pamela R. Edmonds, Leonard G. Gomella, Ethan J. Halpern |
|
113-117 |
Prior Estrogen Therapy as a Predictor of Response to Subsequent Estramustine-Based Chemotherapy in Patients with Androgen-Independent Prostate Cancer Jorge A. Garcia, Vivian Weinberg, Eric J. Small |
|
Translational Medicine | ||
118-123 |
Prostate-Specific Membrane Antigen Vaccines: Naked DNA and Protein Approaches Susan F. Slovin |
|
124-129 |
Molecular Effects of the Isoflavonoid Genistein in Prostate Cancer Jasmin Bektic, Roman Guggenberger, Iris E. Eder, Alexandre E. Pelzer, Andreas P. Berger, Georg Bartsch, Helmut Klocker |
|
Brief Communication | ||
130-133 |
Recent Trends in Surgical Treatment of Localized Prostate Cancer Brian A. Link, Daniel J. Culkin |
|
Case Report | ||
134-137 |
Orbital Metastasis from Prostate Cancer: An Atypical Case of Neuroendocrine Dedifferentiation During Progression from Hormone-Sensitive to Refractory Stage Suneetha Challagundla, Murat Gokden, Sanjaya Viswamitra, Manish Kohli |
|
Current Trial | ||
138-141 |
A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer Elisabeth I. Heath, Melvin Gaskins, Henry C. Pitot, Roberto Pili, Winston Tan, Robert Marschke, Glenn Liu, David Hillman, Fazlul Sarkar, Shijie Sheng, Charles Erlichman, Percy Ivy |
|